Orbem logo Orbem

Health
HQ Country 🇩🇪 Germany

Overview

Munich-based Orbem has raised €55.5 million in a Series B funding round led by Innovation Industries, with participation from Supernova Invest and existing investors. Orbem utilizes AI to industrialize magnetic resonance imaging for non-invasive analysis of biological materials, addressing challenges in agriculture, food production, and health. Their flagship product, Genus Focus, determines the sex of poultry eggs rapidly, offering a humane alternative to culling. The funding will support U.S. expansion and entry into the fruit and vegetable sector.

Products

Loading...

Recent Deals

Investors: Innovation Industries, Supernova Invest
Munich-based Orbem has raised €55.5 million in a Series B funding round led by Innovation Industries, with participation from Supernova Invest and existing investors. Orbem utilizes AI to industrialize magnetic resonance imaging for non-invasive analysis of biological materials, addressing challenges in agriculture, food production, and health. Their flagship product, Genus Focus, determines the sex of poultry eggs rapidly, offering a humane alternative to culling. The funding will support U.S. expansion and entry into the fruit and vegetable sector.
View All Deals in Health →